PlantForm Corp.

PlantForm is proud to be advancing biologics innovation with CDMO services using our cost-effective, plant-based vivoXPRESS manufacturing platform. Learn more: plantformcorp.com/cdmo-services.… #cdmo #biologics #biopharma #BIO2022 #LimitlessTogether

$25MM Investment Opportunity in Plant-Based Pharmaceuticals Company Plantform Corporation is developing plant-made pharmaceuticals for exposure to chemical weapons, among other breakthroughs. Thursday, June 6th, 8:00AM PDT Online event Learn more: streamyard.com/watch/WRkiu9yc… #event #webinar #plantbased #pharmaceuticals #medical #illnesses #clinical #biotechnology #biodefense #vaccines #investment #investing #investors #finance #business #funding #equity

This work beautifully integrates the power of proteomics and metabolomics with the promise of plants for drug discovery. Very excited to see it published! @PlantFormCorp @CNPN_org

We'll be at the International Society for Plant Molecular Farming (ISPMF) Conference May 6-8! 🌿 Thank you to #CanExport Innovation @tcs_sdc for supporting our work to forge new partnerships that bring Canadian biotech innovation to the world! #export #ISPMF2024

Exciting news! @PlantFormCorp and @3dbiofibr have been awarded $1.3M from @NGen_Canada to advance recombinant human collagen fiber manufacturing technology. Read the full news release: plantformcorp.com/news-detail.as… #collagen #biotech #innovation

Read this @BioProcessIntl article about our work leveraging plant-based protein-expression systems for #biodefense applications: bioprocessintl.com/2023/november-…

News Release: @PlantFormCorp and @SwiftPharmaInc announce new licensing agreement to develop plant-made antibodies, proteins and vaccines for global markets Read more: bit.ly/3MkRObC #biopharma #biotech #antibody

Press release: AntoXa Corporation and SwiftPharma Sign Exclusive Collaboration Agreement to Support the Development and Commercialization of a Plant-Made Antibody Against Ricin Exposure Full release: antoxacorp.com/antoxa-corpora…

PlantForm has 2 immediate job openings! 1️⃣ Biotechnology Technician (Guelph or Bolton, ON). 2️⃣ Research Associate 1 (Bolton, ON). See the employment postings here: plantformcorp.com/careers.aspx #biotech #biopharma

Press Release: U.S. Patent Office allows @PlantFormCorp's patent application for novel approach to boost yields of plant-based protein products Full release: plantformcorp.com/news-detail.as… #biopharmaceutical #antibodytherapeutics #innovation

Read more here: plantformcorp.com/news-detail.as… #ricin #biopharma #antibody

The PhD9 antibody drug candidate developed by DRDC prevents ricin from penetrating cells. The process has received United States Patent No. 11,447,789.

Ricin is in the news again: this lethal substance, found naturally in castor beans, is 6,000 times deadlier than cyanide and a tiny amount can cause death within 36 hours. theglobeandmail.com/canada/article…

PRESS RELEASE: PlantForm and @UBC researcher Dr. Joerg Bohlmann receive @glyconet_nce funds to develop novel, plant-based treatment option for Type-2 diabetes Read the full release here: bit.ly/3TwzMFW

PRESS RELEASE: PlantForm Corporation and Bio-Manguinhos/Fiocruz sign new agreement to develop a #biosimilar pembrolizumab cancer drug and up to 5 future products for the Brazilian and other world markets. Full release: bit.ly/3IZJ08y

In our latest blog post, we examine the trends shaping the #biosimilars industry & discuss the impact of innovative techs on biosimilar development. Learn how @PlantFormCorp's vivoXPRESS® & Alto Digital #SPR can streamline biosimilar production. Link: nicoyalife.com/blog/character…

AntoXa, a wholly-owned subsidiary of PlantForm Corporation, has an exclusive license from DRDC to develop and produce the PhD9 monoclonal antibody treatment in plants for sale in markets worldwide.

The patent is for a plant-based manufacturing process to produce an antibody for treatment of ricin exposure, an outcome of R&D by AntoXa Corporation under contract with Defence Research and Development Canada (DRDC), an Agency of the Canadian Department of National Defence.

PRESS RELEASE: U.S. Patent Granted for Made-in-Canada Ricin Antibody Technology Read the full press release: bit.ly/3kus2Hl